Position in IMCR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$45,339,000
+$9,520,800 QoQ
Shares Held
1,428,000
+20.2% QoQ
Ownership
2.77%
of shares outstanding
% of Portfolio
1.26%
of 13F equity value
Holder Rank
#10
of 136 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IMCR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ARMISTICE CAPITAL, LLC holds $1,506,954,940 across 50 Biotechnology names. IMCR ranks #14 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
288,000 | $154,641,600 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,201,342 | $102,342,324 | |
| 3 | INCY |
Incyte Corp
|
900,005 | $102,024,566 | |
| 4 | TVTX |
Travere Therapeutics, Inc.
|
1,572,539 | $89,335,940 | |
| 5 | AGIO |
Agios Pharmaceuticals, Inc.
|
2,400,000 | $89,064,000 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
1,071,395 | $87,393,690 | |
| 7 | DYN |
Dyne Therapeutics, Inc.
|
3,087,226 | $68,567,289 | |
| 8 | IMVT |
Immunovant, Inc.
|
1,736,000 | $66,888,080 |
All Filings in IMCR
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $45,339,000 | 1,428,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $35,818,200 | 1,188,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $38,111,580 | 1,098,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $29,935,920 | 824,000 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $21,275,640 | 678,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $29,017,260 | 978,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $35,400,000 | 1,200,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $39,348,320 | 1,264,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $33,076,640 | 976,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $10,660,000 | 164,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $21,315,840 | 312,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $20,760,000 | 400,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $25,662,880 | 428,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $18,688,320 | 378,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $19,175,520 | 336,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $14,833,040 | 316,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $9,999,080 | 268,000 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $5,382,000 | 180,000 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||